ES8507612A1 - Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide. - Google Patents

Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide.

Info

Publication number
ES8507612A1
ES8507612A1 ES534510A ES534510A ES8507612A1 ES 8507612 A1 ES8507612 A1 ES 8507612A1 ES 534510 A ES534510 A ES 534510A ES 534510 A ES534510 A ES 534510A ES 8507612 A1 ES8507612 A1 ES 8507612A1
Authority
ES
Spain
Prior art keywords
proteinoids
diagnostics
receptors
translated
brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534510A
Other languages
English (en)
Other versions
ES534510A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of ES534510A0 publication Critical patent/ES534510A0/es
Publication of ES8507612A1 publication Critical patent/ES8507612A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

METODO PARA DETERMINAR LA PRESENCIA DE UNA SECUENCIA NATURAL DE RESTOS AMINOACIDOS DE UN PROTEINOIDE.COMPRENDE: A) PROPORCIONAR UN TEJIDO CELULAR QUE PUEDE CONTENER UN PROTEINOIDE O UN DERIVADO PROTEINOIDE; B) MEZCLAR EL TEJIDO DE (A) CON CANTIDADES EFECTIVAS DE UN RECEPTOR BIOLOGICAMENTE ACTIVO O UN CONJUGADO DEL POLIPEPTIDO SINTETICO UNIDO A UN PORTADOR, Y UN GRUPO INDICADOR; C) INCUBAR LA MEZCLA DE (B) DURANTE UN TIEMPO SUFICIENTE PARA QUE SE PRODUZCA UNA REACCION INMUNE; Y D) ENSAYAR LA MEZCLA INCUBADA PARA DETERMINAR LA PRESENCIA DE UNA REACCION INMUNE ENTRE EL PROTEINOIDE O DERIVADO PROTENINOIDE CONTENIDO EN EL TEJIDO CELULAR CEREBRAL Y EL RECEP
ES534510A 1983-07-21 1984-07-20 Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide. Expired ES8507612A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51613683A 1983-07-21 1983-07-21

Publications (2)

Publication Number Publication Date
ES534510A0 ES534510A0 (es) 1985-09-16
ES8507612A1 true ES8507612A1 (es) 1985-09-16

Family

ID=24054282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534510A Expired ES8507612A1 (es) 1983-07-21 1984-07-20 Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide.

Country Status (9)

Country Link
EP (1) EP0135277B1 (es)
JP (1) JPS60190796A (es)
KR (1) KR850000920A (es)
AT (1) ATE23169T1 (es)
AU (1) AU576508B2 (es)
CA (1) CA1247521A (es)
DE (1) DE3461093D1 (es)
ES (1) ES8507612A1 (es)
PH (2) PH21409A (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0241487B1 (en) * 1985-08-28 1998-04-22 PIECZENIK, George Method and means for sorting and identifying biological information
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
EP0297585A3 (en) * 1987-07-01 1990-05-23 Sloan-Kettering Institute For Cancer Research Neuronal polypeptide and methods of production and use thereof
FR2660757B1 (fr) * 1990-04-06 1994-05-27 Immunotech Sa Procede d'identification ou de dosage de proteines et applications.
US6743892B1 (en) 1995-09-11 2004-06-01 La Jolla Cancer Research Foundation Molecules that home to a selected organ in vivo
EP0773441B1 (en) * 1995-09-11 2000-08-02 La Jolla Cancer Research Foundation Molecules that home to a selected organ or tissue in vivo and methods of identifying same
US6068829A (en) 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
US6576239B1 (en) 1996-09-10 2003-06-10 The Burnham Institute Angiogenic homing molecules and conjugates derived therefrom
US6232287B1 (en) 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
US7544767B2 (en) 2002-04-05 2009-06-09 Burnham Institute For Medical Research HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
US8176811B2 (en) * 2004-07-30 2012-05-15 Dana Heavy Vehicle Systems Group, Llc Ribbed cover for drive axle housing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949064A (en) * 1973-10-26 1976-04-06 Baxter Laboratories, Inc. Method of detecting antigens or antibodies
US4205057A (en) * 1978-01-17 1980-05-27 Government Of The United States Cerebrospinal fluid protein fragments

Also Published As

Publication number Publication date
ES534510A0 (es) 1985-09-16
PH21409A (en) 1987-10-15
DE3461093D1 (en) 1986-12-04
PH22909A (en) 1989-01-24
AU3081384A (en) 1985-01-24
ATE23169T1 (de) 1986-11-15
KR850000920A (ko) 1985-03-14
EP0135277B1 (en) 1986-10-29
JPS60190796A (ja) 1985-09-28
EP0135277A1 (en) 1985-03-27
AU576508B2 (en) 1988-09-01
CA1247521A (en) 1988-12-28

Similar Documents

Publication Publication Date Title
HU9303023D0 (en) Peptide nucleicadis and method for producing them
ATE90690T1 (de) Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
DE3461093D1 (en) Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mrnas, receptors, methods and diagnostics using the same
DE69232585D1 (de) Oligosidderivat aus einem polyosidantigen von einem pathogenen erreger
IL126044A0 (en) Engineering affinity ligands for macromolecules
DK1026239T3 (da) Ny fremgangsmåde til at udnytte det immunologiske repertoire
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
IL193886A0 (en) Antibodies that bind to ldcam sequences
PT994903E (pt) Metodos e composicoes para glicoproteinas galactosiladas
IL136728A0 (en) Novel g protein-coupled receptor
BG40318A3 (en) Method for preparing imunoglobuline derivatives of vindezine
ATE186781T1 (de) Verfahren zur herstellung von testelementen
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
EP0257778A3 (en) Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas
DE3873524D1 (de) Iodierte polymere, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel.
DE3482021D1 (de) Verfahren zur erhoehung der milchleistung von milchliefernden kuehen mittels futter, verfahren zur herstellung dieses futters und apparat zur durchfuehrung dieses verfahrens.
EP0861838A3 (en) Process and intermediates for preparing cryptophycin compounds
ATE216778T1 (de) Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein
ATE228580T1 (de) Legierung und verfahren zum herstellen von gegenständen aus dieser legierung
DE69810959D1 (de) Verfahren zur herstellung von pyrrolamiden
WO1992000284A3 (en) Method for forming an amino acid thiohydantoin using an n-substituted ketenimine activator
ES8607269A1 (es) Procedimiento para preparar antraquinon-(oxi-2,2-oxidopropa-nos) mono- y bis-funcionales
DE69000705D1 (de) Kupferderivat oder kupfer- und borderivat enthaltendes schmieroeladditiv, verfahren zu seiner herstellung und dieses additiv enthaltende zusammensetzungen.
NZ237533A (en) Monoclonal antibodies which bind to oncostatin m, cell lines producing them
BG101927A (en) Peprides having growth acceleration properties